<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=1655897" created="04/04/2006" creator="Yo Shidahara"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>1655897</PMID>
<Article>
<ArticleTitle>
<sentence id="S1"><term id="T1" lex="nuclear_transcription_factor" sem="Protein_family_or_group">Nuclear transcription factors</term> that bind to <term id="A1" sem="DNA_domain_or_region">elements of the <term id="T2" lex="IL-2_promoter" sem="DNA_domain_or_region">IL-2 promoter</term>.</term></sentence>
<event KT="Investigation" id="E1">
<type class="Binding"/>
<theme idref="T1"/>
<theme idref="A1"/>
<clue>Nuclear transcription factors that <clueType>bind</clueType> <linkTheme>to</linkTheme> elements of the IL-2 promoter.</clue>
<comment>TPS A1</comment></event>
<sentence id="S2">Induction requirements in <term id="T3" lex="primary_human_T_cell" sem="Cell_natural">primary human T cells</term>.</sentence>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S3">Prior studies have identified several <term id="A101" sem="DNA_domain_or_region">elements</term> that contribute to the activity of the <term id="T4" lex="IL-2_promoter" sem="DNA_domain_or_region">IL-2 promoter</term> in the stimulated <term id="T5" lex="T_cell_line" sem="Cell_cultured">T cell line</term>, <term id="T6" lex="Jurkat" sem="Cell_cultured">Jurkat</term>.</sentence>
<event KT="Analysis" Source="Other" id="E101">
<type class="Regulation"/>
<theme idref="T4"/>
<cause idref="A101"/>
<clue><clueSource>Prior studies</clueSource> have <clueKT>identified</clueKT> several elements that <clueType>contribute</clueType> <linkTheme>to</linkTheme> the activity of the IL-2 promoter <clueLoc>in the stimulated T cell line, Jurkat</clueLoc>.</clue>
</event>
<event KT="Other" id="E102">
<type class="Physiological_process"/>
<theme idref="T5"/>
<clue>Prior studies have identified several elements that contribute to the activity of the IL-2 promoter in the <clueType>stimulated</clueType> T cell line, Jurkat.</clue>
</event>
<sentence id="S4">The sites and their corresponding nuclear binding factors include: <term id="T7" lex="NF-kappa_B" sem="Protein_molecule">NF-kappa B</term>, <term id="T8" lex="AP-1" sem="Protein_molecule">AP-1</term>, <term id="T9" lex="AP-3" sem="Protein_molecule">AP-3</term>, <term id="T10" lex="OCT-1" sem="Protein_molecule">OCT-1</term>, and <term id="T11" lex="NF-AT" sem="Protein_molecule">NF-AT</term>.</sentence>
<sentence id="S5">The latter &quot;<term id="T12" lex="nuclear_factor_for_activated_T_cell" sem="Protein_family_or_group">nuclear factor for <term id="T13" lex="activated_T_cell" sem="Cell_cultured">activated T cells</term></term>&quot; likely contributes to the tissue specificity of <term id="T14" lex="IL-2_gene_expression" sem="Other"><term id="T15" lex="IL-2_gene" sem="DNA_domain_or_region"><term id="T16" lex="IL-2" sem="Protein_molecule">IL-2</term> gene</term> expression</term>.</sentence>
<event KT="Other" id="E2">
<type class="Gene_expression"/>
<theme idref="T15"/>
<clue>The latter &quot;nuclear factor for activated T cells&quot; likely contributes to the tissue specificity of IL-2 gene <clueType>expression</clueType>.</clue>
</event>
<event KT="Other" id="E3">
<type class="Regulation"/>
<theme idref="E2"/>
<clue>The latter &quot;nuclear factor for activated T cells&quot; likely contributes to the <clueLoc>tissue</clueLoc> <clueType>specificity</clueType> <linkTheme>of</linkTheme> IL-2 gene expression.</clue>
</event>
<event CL="L2" KT="Analysis" id="E103" uncertainty="probable">
<type class="Regulation"/>
<theme idref="E3"/>
<cause idref="T12"/>
<clue>The latter &quot;nuclear factor for activated T cells&quot; <clueKT><clueCL>likely</clueCL></clueKT> <clueType>contributes</clueType> <linkTheme>to</linkTheme> the tissue specificity of IL-2 gene expression.</clue>
</event>
<sentence id="S6">Using <term id="T17" lex="electrophoretic_mobility_shift_assay" sem="Other">electrophoretic mobility shift assays</term>, we have studied these <term id="T18" lex="transcription_factor" sem="Protein_family_or_group">transcription factors</term> in <term id="T19" lex="primary_T_cell" sem="Cell_natural">primary T cells</term> from <term id="T20" lex="human_blood" sem="Tissue_natural">human blood</term> to verify their presence in a physiologic setting and to identify the <term id="A102" sem="Other">signals</term> that stimulate <term id="T21" lex="factor_activity" sem="Other">factor activity</term>.</sentence>
<event KT="Investigation" id="E104">
<type class="Positive_regulation"/>
<theme idref="T7"/>
<cause idref="A102"/>
<clue>Using electrophoretic mobility shift assays, we have studied <corefTheme idref1="T7">these transcription factors</corefTheme> in primary T cells from human blood to verify their presence in a physiologic setting and <clueKT>to identify</clueKT> the signals that <clueType>stimulate</clueType> <corefTheme idref1="T7">factor activity</corefTheme>.</clue>
</event>
<event KT="Investigation" id="E105">
<type class="Positive_regulation"/>
<theme idref="T8"/>
<cause idref="A102"/>
<clue>Using electrophoretic mobility shift assays, we have studied <corefTheme idref1="T8">these transcription factors</corefTheme> in primary T cells from human blood to verify their presence in a physiologic setting and <clueKT>to identify</clueKT> the signals that <clueType>stimulate</clueType> <corefTheme idref1="T8">factor activity</corefTheme>.</clue>
</event>
<event KT="Investigation" id="E106">
<type class="Positive_regulation"/>
<theme idref="T9"/>
<cause idref="A102"/>
<clue>Using electrophoretic mobility shift assays, we have studied <corefTheme idref1="T9">these transcription factors</corefTheme> in primary T cells from human blood to verify their presence in a physiologic setting and <clueKT>to identify</clueKT> the signals that <clueType>stimulate</clueType> <corefTheme idref1="T9">factor activity</corefTheme>.</clue>
</event>
<event KT="Investigation" id="E107">
<type class="Positive_regulation"/>
<theme idref="T10"/>
<cause idref="A102"/>
<clue>Using electrophoretic mobility shift assays, we have studied <corefTheme idref1="T10">these transcription factors</corefTheme> in primary T cells from human blood to verify their presence in a physiologic setting and <clueKT>to identify</clueKT> the signals that <clueType>stimulate</clueType> <corefTheme idref1="T10">factor activity</corefTheme>.</clue>
</event>
<event KT="Investigation" id="E108">
<type class="Positive_regulation"/>
<theme idref="T11"/>
<cause idref="A102"/>
<clue>Using electrophoretic mobility shift assays, we have studied <corefTheme idref1="T11">these transcription factors</corefTheme> in primary T cells from human blood to verify their presence in a physiologic setting and <clueKT>to identify</clueKT> the signals that <clueType>stimulate</clueType> <corefTheme idref1="T11">factor activity</corefTheme>.</clue>
</event>
<sentence id="S7">All factors are induced in the <term id="T22" lex="nuclei" sem="Cell_component">nuclei</term> of <term id="T23" lex="T_cell" sem="Cell_natural">T cells</term> upon activation with <term id="T24" lex="mitogen" sem="Protein_family_or_group">mitogens</term> but not with <term id="T25" lex="exogenous_IL-2_growth_factor" sem="Protein_molecule">exogenous <term id="T26" lex="IL-2" sem="Protein_molecule">IL-2</term> growth factor</term>.</sentence>
<event id="E4">
<type class="Positive_regulation"/>
<theme idref="T7"/>
<cause idref="T24"/>
<clue><corefTheme>All factors</corefTheme> are <clueType>induced</clueType> <clueLoc>in the nuclei of T cells</clueLoc> <linkCause>upon activation with</linkCause> mitogens but not with exogenous IL-2 growth factor.</clue>
</event>
<event id="E5">
<type class="Positive_regulation"/>
<theme idref="T8"/>
<cause idref="T24"/>
<clue><corefTheme>All factors</corefTheme> are <clueType>induced</clueType> <clueLoc>in the nuclei of T cells</clueLoc> <linkCause>upon activation with</linkCause> mitogens but not with exogenous IL-2 growth factor.</clue>
</event>
<event id="E6">
<type class="Positive_regulation"/>
<theme idref="T9"/>
<cause idref="T24"/>
<clue><corefTheme>All factors</corefTheme> are <clueType>induced</clueType> <clueLoc>in the nuclei of T cells</clueLoc> <linkCause>upon activation with</linkCause> mitogens but not with exogenous IL-2 growth factor.</clue>
</event>
<event id="E7">
<type class="Positive_regulation"/>
<theme idref="T10"/>
<cause idref="T24"/>
<clue><corefTheme>All factors</corefTheme> are <clueType>induced</clueType> <clueLoc>in the nuclei of T cells</clueLoc> <linkCause>upon activation with</linkCause> mitogens but not with exogenous IL-2 growth factor.</clue>
</event>
<event id="E8">
<type class="Positive_regulation"/>
<theme idref="T11"/>
<cause idref="T24"/>
<clue><corefTheme>All factors</corefTheme> are <clueType>induced</clueType> <clueLoc>in the nuclei of T cells</clueLoc> <linkCause>upon activation with</linkCause> mitogens but not with exogenous IL-2 growth factor.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E9">
<type class="Positive_regulation"/>
<theme idref="T7"/>
<cause idref="T26"/>
<clue><corefTheme>All factors</corefTheme> are <clueType>induced</clueType> <clueLoc>in the nuclei of T cells</clueLoc> <linkCause>upon activation</linkCause> with mitogens but <cluePolarity>not</cluePolarity> <linkCause>with</linkCause> exogenous IL-2 growth factor.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E10">
<type class="Positive_regulation"/>
<theme idref="T8"/>
<cause idref="T26"/>
<clue><corefTheme>All factors</corefTheme> are <clueType>induced</clueType> <clueLoc>in the nuclei of T cells</clueLoc> <linkCause>upon activation</linkCause> with mitogens but <cluePolarity>not</cluePolarity> <linkCause>with</linkCause> exogenous IL-2 growth factor.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E11">
<type class="Positive_regulation"/>
<theme idref="T9"/>
<cause idref="T26"/>
<clue><corefTheme>All factors</corefTheme> are <clueType>induced</clueType> <clueLoc>in the nuclei of T cells</clueLoc> <linkCause>upon activation</linkCause> with mitogens but <cluePolarity>not</cluePolarity> <linkCause>with</linkCause> exogenous IL-2 growth factor.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E12">
<type class="Positive_regulation"/>
<theme idref="T10"/>
<cause idref="T26"/>
<clue><corefTheme>All factors</corefTheme> are <clueType>induced</clueType> <clueLoc>in the nuclei of T cells</clueLoc> <linkCause>upon activation</linkCause> with mitogens but <cluePolarity>not</cluePolarity> <linkCause>with</linkCause> exogenous IL-2 growth factor.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E13">
<type class="Positive_regulation"/>
<theme idref="T11"/>
<cause idref="T26"/>
<clue><corefTheme>All factors</corefTheme> are <clueType>induced</clueType> <clueLoc>in the nuclei of T cells</clueLoc> <linkCause>upon activation</linkCause> with mitogens but <cluePolarity>not</cluePolarity> <linkCause>with</linkCause> exogenous IL-2 growth factor.</clue>
</event>
<sentence id="S8">However, the <term id="A104" sem="Other">signaling</term> requirements and sensitivity to <term id="T27" lex="protein_synthesis_inhibitor" sem="Other"><term id="A103" sem="Other">protein synthesis</term> inhibitors</term> differ considerably.</sentence>
<event id="E109">
<type class="Positive_regulation"/>
<theme idref="T7"/>
<cause idref="A104"/>
<clue>However, <corefTheme>the</corefTheme> signaling <clueType>requirements</clueType> and sensitivity to protein synthesis inhibitors differ considerably.</clue>
</event>
<event id="E110">
<type class="Positive_regulation"/>
<theme idref="T8"/>
<cause idref="A104"/>
<clue>However, <corefTheme>the</corefTheme> signaling <clueType>requirements</clueType> and sensitivity to protein synthesis inhibitors differ considerably.</clue>
</event>
<event id="E111">
<type class="Positive_regulation"/>
<theme idref="T9"/>
<cause idref="A104"/>
<clue>However, <corefTheme>the</corefTheme> signaling <clueType>requirements</clueType> and sensitivity to protein synthesis inhibitors differ considerably.</clue>
</event>
<event id="E112">
<type class="Positive_regulation"/>
<theme idref="T10"/>
<cause idref="A104"/>
<clue>However, <corefTheme>the</corefTheme> signaling <clueType>requirements</clueType> and sensitivity to protein synthesis inhibitors differ considerably.</clue>
</event>
<event id="E113">
<type class="Positive_regulation"/>
<theme idref="T11"/>
<cause idref="A104"/>
<clue>However, <corefTheme>the</corefTheme> signaling <clueType>requirements</clueType> and sensitivity to protein synthesis inhibitors differ considerably.</clue>
</event>
<event id="E114">
<type class="Negative_regulation"/>
<theme idref="A103"/>
<clue>However, the signaling requirements and sensitivity to protein synthesis <clueType>inhibitors</clueType> differ considerably.</clue>
</event>
<event id="E115">
<type/>
<theme idref="T7"/>
<cause idref="T27"/>
<clue>However, the signaling requirements and <clueType>sensitivity</clueType> <linkCause>to</linkCause> protein synthesis inhibitors differ considerably.</clue>
<comment>SENSITIVITY</comment></event>
<event id="E116">
<type/>
<theme idref="T8"/>
<cause idref="T27"/>
<clue>However, the signaling requirements and <clueType>sensitivity</clueType> <linkCause>to</linkCause> protein synthesis inhibitors differ considerably.</clue>
<comment>SENSITIVITY</comment></event>
<event id="E117">
<type/>
<theme idref="T9"/>
<cause idref="T27"/>
<clue>However, the signaling requirements and <clueType>sensitivity</clueType> <linkCause>to</linkCause> protein synthesis inhibitors differ considerably.</clue>
<comment>SENSITIVITY</comment></event>
<event id="E118">
<type/>
<theme idref="T10"/>
<cause idref="T27"/>
<clue>However, the signaling requirements and <clueType>sensitivity</clueType> <linkCause>to</linkCause> protein synthesis inhibitors differ considerably.</clue>
<comment>SENSITIVITY</comment></event>
<event id="E119">
<type/>
<theme idref="T11"/>
<cause idref="T27"/>
<clue>However, the signaling requirements and <clueType>sensitivity</clueType> <linkCause>to</linkCause> protein synthesis inhibitors differ considerably.</clue>
<comment>SENSITIVITY</comment></event>
<sentence id="S9">Only the activities for <cons id="T28" lex="(AND NF-AT_site AP-1_site)" sem="(AND DNA_domain_or_region DNA_domain_or_region)"><frag id="F1"><term id="A2" sem="DNA_domain_or_region">NF-AT</term></frag> and <frag id="F2"><term id="A3" sem="DNA_domain_or_region">AP-1</term></frag> <frag id="F3"><term id="A4" sem="DNA_domain_or_region">sites</term></frag></cons> require two signals for optimal induction, i.e., <term id="T29" lex="PMA" sem="Organic_compound_other">PMA</term> plus either <term id="T30" lex="lectin" sem="Protein_family_or_group">lectin</term> or <term id="T31" lex="antibody" sem="Protein_family_or_group">antibody</term> <term id="A5" sem="Protein_family_or_group">to</term> the <term id="T32" lex="CD3" sem="Protein_molecule">CD3</term> or <term id="T33" lex="CD28_surface_molecule" sem="Protein_molecule">CD28 surface molecules</term>.</sentence>
<event Manner="High" id="E14">
<type class="Positive_regulation"/>
<theme idref="A2" idref1="A4"/>
<cause idref="T29"/>
<cause idref="T30"/>
<clue>Only the activities for NF-AT and AP-1 sites <clueType>require</clueType> <corefCause>two signals</corefCause> <clueType>for</clueType> <clueManner>optimal</clueManner> <clueType>induction</clueType>, i.e., PMA <linkCause>plus</linkCause> either lectin or antibody to the CD3 or CD28 surface molecules.</clue>
</event>
<event Manner="High" id="E15">
<type class="Positive_regulation"/>
<theme idref="A2" idref1="A4"/>
<cause idref="T29"/>
<cause idref="T31" idref1="A5" idref2="T32"/>
<clue>Only the activities for NF-AT and AP-1 sites <clueType>require</clueType> <corefCause>two signals</corefCause> <clueType>for</clueType> <clueManner>optimal</clueManner> <clueType>induction</clueType>, i.e., PMA <linkCause>plus</linkCause> either lectin or antibody to the CD3 or CD28 surface molecules.</clue>
</event>
<event Manner="High" id="E16">
<type class="Positive_regulation"/>
<theme idref="A2" idref1="A4"/>
<cause idref="T29"/>
<cause idref="T31" idref1="A5" idref2="T33"/>
<clue>Only the activities for NF-AT and AP-1 sites <clueType>require</clueType> <corefCause>two signals</corefCause> <clueType>for</clueType> <clueManner>optimal</clueManner> <clueType>induction</clueType>, i.e., PMA plus either lectin or antibody to the CD3 or CD28 surface molecules.</clue>
</event>
<event Manner="High" id="E17">
<type class="Positive_regulation"/>
<theme idref="A3" idref1="A4"/>
<cause idref="T29"/>
<cause idref="T30"/>
<clue>Only the activities for NF-AT and AP-1 sites <clueType>require</clueType> <corefCause>two signals</corefCause> <clueType>for</clueType> <clueManner>optimal</clueManner> <clueType>induction</clueType>, i.e., PMA plus either lectin or antibody to the CD3 or CD28 surface molecules.</clue>
</event>
<event Manner="High" id="E18">
<type class="Positive_regulation"/>
<theme idref="A3" idref1="A4"/>
<cause idref="T29"/>
<cause idref="T31" idref1="A5" idref2="T32"/>
<clue>Only the activities for NF-AT and AP-1 sites <clueType>require</clueType> <corefCause>two signals</corefCause> <clueType>for</clueType> <clueManner>optimal</clueManner> <clueType>induction</clueType>, i.e., PMA plus either lectin or antibody to the CD3 or CD28 surface molecules.</clue>
</event>
<event Manner="High" id="E35">
<type class="Positive_regulation"/>
<theme idref="A3" idref1="A4"/>
<cause idref="T29"/>
<cause idref="T31" idref1="A5" idref2="T33"/>
<clue>Only the activities for NF-AT and AP-1 sites <clueType>require</clueType> <corefCause>two signals</corefCause> <clueType>for</clueType> <clueManner>optimal</clueManner> <clueType>induction</clueType>, i.e., PMA plus either lectin or antibody to the CD3 or CD28 surface molecules.</clue>
</event>
<sentence id="S10">Other factors are induced by <term id="T34" lex="lectin" sem="Protein_family_or_group">lectin</term>, <term id="T35" lex="antibody" sem="Protein_family_or_group">antibody</term>, and/or <term id="A6" sem="Carbohydrate">PMA</term> alone.</sentence>
<event id="E19">
<type class="Positive_regulation"/>
<theme idref="T7"/>
<cause idref="T34"/>
<clue><corefTheme>Other factors</corefTheme> are <clueType>induced</clueType> <linkCause>by</linkCause> lectin, antibody, and/or PMA alone.</clue>
</event>
<event id="E20">
<type class="Positive_regulation"/>
<theme idref="T9"/>
<cause idref="T34"/>
<clue><corefTheme>Other factors</corefTheme> are <clueType>induced</clueType> <linkCause>by</linkCause> lectin, antibody, and/or PMA alone.</clue>
</event>
<event id="E21">
<type class="Positive_regulation"/>
<theme idref="T10"/>
<cause idref="T34"/>
<clue><corefTheme>Other factors</corefTheme> are <clueType>induced</clueType> <linkCause>by</linkCause> lectin, antibody, and/or PMA alone.</clue>
</event>
<event id="E22">
<type class="Positive_regulation"/>
<theme idref="T7"/>
<cause idref="T31" idref1="A5" idref2="T32"/>
<clue><corefTheme>Other factors</corefTheme> are <clueType>induced</clueType> <linkCause>by</linkCause> lectin, <corefCause>antibody</corefCause>, and/or PMA alone.</clue>
</event>
<event id="E36">
<type class="Positive_regulation"/>
<theme idref="T7"/>
<cause idref="T31" idref1="A5" idref2="T33"/>
<clue><corefTheme>Other factors</corefTheme> are <clueType>induced</clueType> <linkCause>by</linkCause> lectin, <corefCause>antibody</corefCause>, and/or PMA alone.</clue>
</event>
<event id="E23">
<type class="Positive_regulation"/>
<theme idref="T9"/>
<cause idref="T31" idref1="A5" idref2="T32"/>
<clue><corefTheme>Other factors</corefTheme> are <clueType>induced</clueType> <linkCause>by</linkCause> lectin, <corefCause>antibody</corefCause>, and/or PMA alone.</clue>
</event>
<event id="E37">
<type class="Positive_regulation"/>
<theme idref="T9"/>
<cause idref="T31" idref1="A5" idref2="T33"/>
<clue><corefTheme>Other factors</corefTheme> are <clueType>induced</clueType> <linkCause>by</linkCause> lectin, <corefCause>antibody</corefCause>, and/or PMA alone.</clue>
</event>
<event id="E24">
<type class="Positive_regulation"/>
<theme idref="T10"/>
<cause idref="T31" idref1="A5" idref2="T32"/>
<clue><corefTheme>Other factors</corefTheme> are <clueType>induced</clueType> <linkCause>by</linkCause> lectin, <corefCause>antibody</corefCause>, and/or PMA alone.</clue>
</event>
<event id="E38">
<type class="Positive_regulation"/>
<theme idref="T10"/>
<cause idref="T31" idref1="A5" idref2="T33"/>
<clue><corefTheme>Other factors</corefTheme> are <clueType>induced</clueType> <linkCause>by</linkCause> lectin, <corefCause>antibody</corefCause>, and/or PMA alone.</clue>
</event>
<event id="E25">
<type class="Positive_regulation"/>
<theme idref="T7"/>
<cause idref="A6"/>
<clue><corefTheme>Other factors</corefTheme> are <clueType>induced</clueType> <linkCause>by</linkCause> lectin, antibody, and/or PMA alone.</clue>
</event>
<event id="E26">
<type class="Positive_regulation"/>
<theme idref="T9"/>
<cause idref="A6"/>
<clue><corefTheme>Other factors</corefTheme> are <clueType>induced</clueType> <linkCause>by</linkCause> lectin, antibody, and/or PMA alone.</clue>
</event>
<event id="E27">
<type class="Positive_regulation"/>
<theme idref="T10"/>
<cause idref="A6"/>
<clue><corefTheme>Other factors</corefTheme> are <clueType>induced</clueType> <linkCause>by</linkCause> lectin, antibody, and/or PMA alone.</clue>
</event>
<sentence id="S11">After appropriate <term id="T36" lex="stimulation" sem="Other">stimulation</term>, both <term id="T37" lex="NF-AT" sem="Protein_molecule">NF-AT</term> and <term id="T38" lex="AP-1" sem="Protein_molecule">AP-1</term> are peculiarly sensitive to the <term id="T39" lex="protein_synthesis_inhibitor" sem="Other"><term id="A105" sem="Other">protein synthesis</term> inhibitor</term> <term id="T40" lex="anisomycin" sem="Organic_compound_other">anisomycin</term>.</sentence>
<event id="E28">
<type class="Positive_regulation"/>
<theme idref="T37"/>
<clue>After appropriate <clueType>stimulation</clueType>, both NF-AT and AP-1 are peculiarly sensitive to the protein synthesis inhibitor anisomycin.</clue>
</event>
<event id="E29">
<type class="Positive_regulation"/>
<theme idref="T38"/>
<clue>After appropriate <clueType>stimulation</clueType>, both NF-AT and AP-1 are peculiarly sensitive to the protein synthesis inhibitor anisomycin.</clue>
</event>
<event id="E30">
<type/>
<theme idref="E28"/>
<cause idref="T40"/>
<clue><clueTime>After appropriate stimulation</clueTime>, both NF-AT and AP-1 are peculiarly <clueType>sensitive</clueType> <linkCause>to</linkCause> the protein synthesis inhibitor anisomycin.</clue>
<comment>SENSITIVITY</comment></event>
<event id="E31">
<type/>
<theme idref="E29"/>
<cause idref="T40"/>
<clue><clueTime>After appropriate stimulation</clueTime>, both NF-AT and AP-1 are peculiarly <clueType>sensitive</clueType> <linkCause>to</linkCause> the protein synthesis inhibitor anisomycin.</clue>
<comment>SENSITIVITY</comment></event>
<event id="E120">
<type class="Negative_regulation"/>
<theme idref="A105"/>
<cause idref="T40"/>
<clue>After appropriate stimulation, both NF-AT and AP-1 are peculiarly sensitive to the protein synthesis <clueType>inhibitor</clueType> anisomycin.</clue>
</event>
<sentence id="S12">Our data correlate the activity of <term id="T41" lex="NF-AT" sem="Protein_molecule">NF-AT</term> and <term id="T42" lex="AP-1" sem="Protein_molecule">AP-1</term> in <term id="T43" lex="gel_shift_assay" sem="Other">gel shift assays</term> with the <term id="A106" sem="Other">two signals</term> requirements for <term id="T44" lex="IL-2_gene_expression" sem="Other"><term id="T45" lex="IL-2_gene" sem="DNA_domain_or_region"><term id="T46" lex="IL-2" sem="Protein_molecule">IL-2</term> gene</term> expression</term>.</sentence>
<event KT="Other" id="E32">
<type class="Gene_expression"/>
<theme idref="T45"/>
<clue>Our data correlate the activity of NF-AT and AP-1 in gel shift assays with the two signals requirements for IL-2 gene <clueType>expression</clueType>.</clue>
</event>
<event KT="Other" id="E121">
<type class="Positive_regulation"/>
<theme idref="E32"/>
<cause idref="A106"/>
<clue>Our data correlate the activity of NF-AT and AP-1 in gel shift assays with the two signals <clueType>requirements</clueType> <linkTheme>for</linkTheme> IL-2 gene expression.</clue>
</event>
<event KT="Analysis" id="E33">
<type class="Correlation"/>
<theme idref="T41"/>
<theme idref="E121"/>
<clue>Our data <clueType><clueKT>correlate</clueKT></clueType> the activity of NF-AT and AP-1 in gel shift assays <linkTheme>with</linkTheme> the two signals requirements for IL-2 gene expression.</clue>
</event>
<event KT="Analysis" id="E34">
<type class="Correlation"/>
<theme idref="T42"/>
<theme idref="E121"/>
<clue>Our data <clueType><clueKT>correlate</clueKT></clueType> the activity of NF-AT and AP-1 in gel shift assays <linkTheme>with</linkTheme> the two signals requirements for IL-2 gene expression.</clue>
</event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
